Lite Strategy, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Lite Strategy, Inc. (LITS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $3.49 per share for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-08.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2022-09-08
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2022 was $3.49, a 71.08% increase from fiscal 2021.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2021 was $2.04, a 37.42% decline from fiscal 2020.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2020 was $3.26, a 50.23% increase from fiscal 2019.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2019 was $2.17, a 17.93% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2022-06-30 | $3.49 10-K · filed 2022-09-08 |
| 2021-06-30 | $2.04 10-K/A · filed 2022-05-23 |
| 2020-06-30 | $3.26 10-K · filed 2020-09-09 |
| 2019-06-30 | $2.17 10-K · filed 2019-08-28 |
| 2018-06-30 | $1.84 10-K · filed 2018-08-30 |
| 2017-06-30 | $2.60 10-K · filed 2017-09-05 |
| 2016-06-30 | $3.53 10-K · filed 2016-09-06 |
| 2015-06-30 | $6.62 10-K · filed 2015-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |